Hasnain Faheem 4
4 · Kura Oncology, Inc. · Filed Mar 24, 2025
Insider Transaction Report
Form 4
Hasnain Faheem
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-21$6.32/sh+22,682$143,350→ 46,665 total - Sale
Common Stock
2025-03-21$8.00/sh−22,682$181,456→ 23,983 total
Footnotes (2)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 20, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $8.00 to $8.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.